Lack of Diversity Costing Hollywood Money

By Sheryl Estrada


According to 2015 Hollywood Diversity Report: Flipping the Script,” which makes a correlation between diversity and revenue in Tinseltown, business as usual “may soon be unsustainable” as “diversity sells.”

The report is the second in a series from the Ralph J. Bunche Center for African American Studies at UCLA. It examines relationships between diversity and the bottom line in the Hollywood entertainment industry. The survey consists of the top 200 film releases in 2012 and 2013, and all broadcast, cable and digital-platform television programs from the 201213 season.

Films with a relatively diverse cast continue to excel. The report indicates that out of 163 films released in 2013, films with 21 to 30 percent Blacks/Latinos/Asians earned $143.3 million. As a benchmark, authors included that films in 2011 with the same percentage earned $160.1 million. This implies movies with 21 to 30 percent Blacks/Latinos/Asians incur the greatest return on investment, which factors a film’s budget into the analysis.

In 2012, the median worldwide box office was highest for the 15 films with casts that were from 31 to 40 percent Blacks/Latinos/Asians, at $130.5 million. Interestingly, these films included Django Unchained and Men in Black 3, both with Black male leads.

The authors also noted that in 2013, 50 films with casts of 10 percent or less Blacks/Latinos/Asians only earned $53.2 million.

Consumers are seeking diverse content created with the contributions of diverse talent. However, Hollywood’s professional academies, which are dominated by white males, continue to revel in the work of white males “as a matter of course, insisting that they do so in the name of talent and artistic merit.”

An example is the acting nominees for this year’s Academy Awards, which for only the second time in almost two decades were an entirely white group of actors and actresses.

The Film Industry in 2013

  • 94 percent of CEOs and/or chairs were white males
  • 92 percent of senior management were white
  • Women directed only 6 percent of theatrical films
  • Ethnic minorities received only 17 percent of the lead roles

“Because of the high risk associated with the typical project most new television shows fail, most films underperform individual stakeholders in the industry (white males) look to surround themselves with other individuals with whom they feel comfortable, with whom they feel they have the best prospects for producing a successful project,” the authors wrote. “These latter individuals, of course, tend to think and look like the former, thereby reproducing an industry culture that routinely devalues the talent of minorities and women.”

The percentages of female and Black/Latino/Asian actors, writers, directors and producers in films and TV ranges from less than 10 to 50 percent of their actual population percentage.

The “2014 Hollywood Diversity Report: Making Sense of the Disconnect,” also showed that Blacks/Latinos/Asians and women were not making progress in regards to influential Hollywood positions, compared with the actual demographics of the U.S. population.The industry hasn’t improved much.

Latest News

What Friends Tell Friends: Choose Kaiser Permanente

Originally published on about.kaiserpermanente.org. Integrated, nonprofit health plan tops NICE Satmetrix customer experience benchmark study for 10th straight year. For the 10th year in a row, more people would recommend Kaiser Permanente to a friend or colleague than any other health plan in the nation, according to the recently released…

Cesar Conde

NBCUniversal Sets Ambitious 50% Diversity Goal for Women, People of Color

Cesar Conde, chairman at NBCUniversal News Group, announced a groundbreaking goal to have a 50% diverse workforce at NBCUniversal, according to Deadline. Conde, the first Latino in this role, outlined his plans in an internal video for employees on Wednesday. The ultimate goal is for NBCUniversal, No. 7 on DiversityInc’s 2020…

Mastercard Expands ShopOpenings.com to the U.S. & Canada, Delivering a Search Tool That Identifies What Stores Near You Are Open for Business

Originally published on mastercardcontentexchange.com. Search solution complements new Digital Acceleration for Small Business global initiative which helps small businesses advance digitally and drive online commerce As businesses seek to draw customers back both in store and online, Mastercard is introducing new tools to support them. Today, Mastercard announced the geographic…

TIAA Launches Programs to Raise Awareness of Racial Injustice and Support Communities in Need through the “Be The Change” Initiative

On June 30, TIAA announced new virtual programs designed to raise awareness of racial injustice and support communities in need as a part of the company’s recently launched “Be the Change” initiative. One is TIAA’s “Race Against Racism,” an effort in support of The Innocence Project which included more than…

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

Originally published on jnj.com. Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic In 2020, the initiative aims to reach at least 125,000 patients and could…

Toyota, Alabama A&M and Huntsville Hospital Collaborate to Make COVID-19 Testing Easier

Originally published on pressroom.toyota.com. $100,000 grant provides free service to the community Alabama A & M University (AAMU), Huntsville Hospital and Toyota are developing a mobile health clinic initiative to provide free COVID-19 testing to underserved communities in Madison County. Launching later this year, the mobile medical clinic program has…

Sanofi and Regeneron Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

Originally published on sanofi.com. Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo)….